Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Nakachi

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Japanese Journal of Clinical Oncology|November 24, 2005
Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancerJunji Furuse, Hiroshi Ishii, Takuji Okusaka, et al.
Pancreas|February 2, 2011
Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinomaChigusa Morizane, Takuji Okusaka, Satoshi Morita, et al.
International Journal of Cancer|April 19, 2012
Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancerAkira Imoto, Shuichi Mitsunaga, Masatoshi Inagaki, et al.
Japanese Journal of Clinical Oncology|February 21, 2018
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|August 4, 2012
Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trialTetsuhide Ito, Takuji Okusaka, Masafumi Ikeda, et al.
Annals of Surgical Oncology|July 14, 2023
A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT)Shin Kobayashi, Masafumi Ikeda, Kohei Nakachi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|February 19, 2011
Borderline resectable pancreatic cancer: rationale for multidisciplinary treatmentShinichiro Takahashi, Taira Kinoshita, Masaru Konishi, et al.
Oncology|December 2, 2005
A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerHideki Ueno, Takuji Okusaka, Masafumi Ikeda, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerChigusa Morizane, Takuji Okusaka, Junji Furuse, et al.
Hepato-Gastroenterology|July 11, 2008
Hepatectomy for hepatocellular carcinoma patients who meet the Milan criteriaHiroshi Ishii, Junji Furuse, Taira Kinoshita, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Japanese Journal of Clinical Oncology|November 24, 2005
Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancerJunji Furuse, Hiroshi Ishii, Takuji Okusaka, et al.
Pancreas|February 2, 2011
Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinomaChigusa Morizane, Takuji Okusaka, Satoshi Morita, et al.
International Journal of Cancer|April 19, 2012
Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancerAkira Imoto, Shuichi Mitsunaga, Masatoshi Inagaki, et al.
Japanese Journal of Clinical Oncology|February 21, 2018
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|August 4, 2012
Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trialTetsuhide Ito, Takuji Okusaka, Masafumi Ikeda, et al.
Annals of Surgical Oncology|July 14, 2023
A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT)Shin Kobayashi, Masafumi Ikeda, Kohei Nakachi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|February 19, 2011
Borderline resectable pancreatic cancer: rationale for multidisciplinary treatmentShinichiro Takahashi, Taira Kinoshita, Masaru Konishi, et al.
Oncology|December 2, 2005
A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerHideki Ueno, Takuji Okusaka, Masafumi Ikeda, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerChigusa Morizane, Takuji Okusaka, Junji Furuse, et al.
Hepato-Gastroenterology|July 11, 2008
Hepatectomy for hepatocellular carcinoma patients who meet the Milan criteriaHiroshi Ishii, Junji Furuse, Taira Kinoshita, et al.
Pageof 5